{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:03:05Z","timestamp":1790888585117,"version":"4.1.0"},"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2009,10,9]],"date-time":"2009-10-09T00:00:00Z","timestamp":1255046400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1000610","type":"journal-article","created":{"date-parts":[[2009,10,8]],"date-time":"2009-10-08T17:56:04Z","timestamp":1255024564000},"page":"e1000610","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":77,"title":["IL-10 Signaling Blockade Controls Murine West Nile Virus Infection"],"prefix":"10.1371","volume":"5","author":[{"given":"Fengwei","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrence","family":"Town","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Kamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarah M.","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth R.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Flavell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erol","family":"Fikrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,10,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.7326\/0003-4819-137-3-200208060-00009","article-title":"West Nile virus: a primer for the clinician.","volume":"137","author":"LR Petersen","year":"2002","journal-title":"Ann Intern Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1172\/JCI21623","article-title":"West Nile virus: a growing concern?","volume":"113","author":"LH Gould","year":"2004","journal-title":"J Clin Invest"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor.","volume":"19","author":"KW Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0092-8674(93)80068-P","article-title":"Interleukin-10-deficient mice develop chronic enterocolitis.","volume":"75","author":"R Kuhn","year":"1993","journal-title":"Cell"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"798","DOI":"10.4049\/jimmunol.157.2.798","article-title":"In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha.","volume":"157","author":"RT Gazzinelli","year":"1996","journal-title":"J Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1126\/science.2173142","article-title":"Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1.","volume":"250","author":"DH Hsu","year":"1990","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1084\/jem.20061462","article-title":"Resolution of a chronic viral infection after interleukin-10 receptor blockade.","volume":"203","author":"M Ejrnaes","year":"2006","journal-title":"J Exp Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm1492","article-title":"Interleukin-10 determines viral clearance or persistence in vivo.","volume":"12","author":"DG Brooks","year":"2006","journal-title":"Nat Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2172-8-8","article-title":"Interleukin-10 plays an early role in generating virus-specific T cell anergy.","volume":"8","author":"CH Maris","year":"2007","journal-title":"BMC Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"10964","DOI":"10.1128\/JVI.01646-08","article-title":"Early B-cell activation after West Nile virus infection requires alpha\/beta interferon but not antigen receptor signaling.","volume":"82","author":"WE Purtha","year":"2008","journal-title":"J Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"13350","DOI":"10.1128\/JVI.79.21.13350-13361.2005","article-title":"Alpha\/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival.","volume":"79","author":"MA Samuel","year":"2005","journal-title":"J Virol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1128\/JVI.00274-06","article-title":"Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection.","volume":"80","author":"B Shrestha","year":"2006","journal-title":"J Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.1128\/JVI.00918-08","article-title":"Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection.","volume":"82","author":"S Daffis","year":"2008","journal-title":"J Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1086\/591466","article-title":"Interferon and interferon-induced chemokine expression is associated with control of acute viremia in West Nile virus-infected blood donors.","volume":"198","author":"LH Tobler","year":"2008","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"12060","DOI":"10.1128\/JVI.01650-06","article-title":"CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system.","volume":"80","author":"EM Sitati","year":"2006","journal-title":"J Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"8568","DOI":"10.4049\/jimmunol.181.12.8568","article-title":"West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection.","volume":"181","author":"JD Brien","year":"2008","journal-title":"J Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.1128\/JVI.78.15.8312-8321.2004","article-title":"Role of CD8+ T cells in control of West Nile virus infection.","volume":"78","author":"B Shrestha","year":"2004","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/JVI.80.1.119-129.2006","article-title":"CD8+ T cells require perforin to clear West Nile virus from infected neurons.","volume":"80","author":"B Shrestha","year":"2006","journal-title":"J Virol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1099\/vir.0.81306-0","article-title":"CD8(+) T cell-mediated immune responses in West Nile virus (Sarafend strain) encephalitis are independent of gamma interferon.","volume":"87","author":"Y Wang","year":"2006","journal-title":"J Gen Virol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"11457","DOI":"10.1128\/JVI.79.17.11457-11466.2005","article-title":"Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis.","volume":"79","author":"RS Klein","year":"2005","journal-title":"J Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.vaccine.2008.02.009","article-title":"The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus.","volume":"26","author":"B Shrestha","year":"2008","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1574-695X.2008.00430.x","article-title":"Role of two distinct gammadelta T cell subsets during West Nile virus infection.","volume":"53","author":"T Welte","year":"2008","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.4049\/jimmunol.177.3.1825","article-title":"Gamma delta T cells facilitate adaptive immunity against West Nile virus infection in mice.","volume":"177","author":"T Wang","year":"2006","journal-title":"J Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.4049\/jimmunol.171.5.2524","article-title":"IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection.","volume":"171","author":"T Wang","year":"2003","journal-title":"J Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jlb.55.2.227","article-title":"Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages.","volume":"55","author":"C Bogdan","year":"1994","journal-title":"J Leukoc Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/eji.1830190731","article-title":"Human T cells and interleukin 4 inhibit the release of interleukin 1 induced by lipopolysaccharide in serum-free cultures of autologous monocytes.","volume":"19","author":"L Weiss","year":"1989","journal-title":"Eur J Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1073\/pnas.86.10.3803","article-title":"Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2.","volume":"86","author":"PH Hart","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.4049\/jimmunol.146.10.3431","article-title":"IL-1 expression in human monocytes is transcriptionally and posttranscriptionally regulated by IL-4.","volume":"146","author":"RP Donnelly","year":"1991","journal-title":"J Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/362248a0","article-title":"Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses.","volume":"362","author":"A Minty","year":"1993","journal-title":"Nature"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1073\/pnas.90.8.3735","article-title":"Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function.","volume":"90","author":"AN McKenzie","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1128\/JVI.02621-07","article-title":"Icam-1 participates in the entry of west nile virus into the central nervous system.","volume":"82","author":"J Dai","year":"2008","journal-title":"J Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"10349","DOI":"10.1128\/JVI.00935-08","article-title":"Toll-like receptor 3 has a protective role against West Nile virus infection.","volume":"82","author":"S Daffis","year":"2008","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.immuni.2008.11.012","article-title":"Toll-like receptor 7 mitigates lethal West Nile encephalitis via interleukin 23-dependent immune cell infiltration and homing.","volume":"30","author":"T Town","year":"2009","journal-title":"Immunity"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/nm1140","article-title":"Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis.","volume":"10","author":"T Wang","year":"2004","journal-title":"Nat Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.4049\/jimmunol.181.3.2084","article-title":"Drak2 contributes to West Nile virus entry into the brain and lethal encephalitis.","volume":"181","author":"S Wang","year":"2008","journal-title":"J Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/eji.200737196","article-title":"Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection.","volume":"37","author":"JD Brien","year":"2007","journal-title":"Eur J Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/eji.200737192","article-title":"Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis.","volume":"37","author":"WE Purtha","year":"2007","journal-title":"Eur J Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1084\/jem.20062175","article-title":"Conventional T-bet(+)Foxp3(\u2212) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection.","volume":"204","author":"D Jankovic","year":"2007","journal-title":"J Exp Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e1000004","DOI":"10.1371\/journal.ppat.1000004","article-title":"IL-10 from CD4CD25Foxp3CD127 adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection.","volume":"4","author":"KN Couper","year":"2008","journal-title":"PLoS Pathog"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.immuni.2006.09.013","article-title":"Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse.","volume":"25","author":"M Kamanaka","year":"2006","journal-title":"Immunity"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1146\/annurev.immunol.22.012703.104622","article-title":"Interleukin-10 and related cytokines and receptors.","volume":"22","author":"S Pestka","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.4049\/jimmunol.180.9.5771","article-title":"IL-10: the master regulator of immunity to infection.","volume":"180","author":"KN Couper","year":"2008","journal-title":"J Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1172\/JCI200420515","article-title":"Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection.","volume":"113","author":"D Accapezzato","year":"2004","journal-title":"J Clin Invest"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3748\/wjg.v8.i3.562","article-title":"HCV-specific cytokine induction in monocytes of patients with different outcomes of hepatitis C.","volume":"8","author":"RP Woitas","year":"2002","journal-title":"World J Gastroenterol"},{"key":"ref45","first-page":"48","article-title":"Serum IL-10 levels in HIV-positive subjects: correlation with CDC stages.","volume":"8","author":"F Ameglio","year":"1994","journal-title":"J Biol Regul Homeost Agents"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1172\/JCI117031","article-title":"Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus.","volume":"93","author":"M Clerici","year":"1994","journal-title":"J Clin Invest"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1053\/jhep.2001.21147","article-title":"Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.","volume":"33","author":"MA Rico","year":"2001","journal-title":"Hepatology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1084\/jem.20071948","article-title":"IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection.","volume":"205","author":"DG Brooks","year":"2008","journal-title":"J Exp Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1182\/blood-2002-10-3065","article-title":"B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression.","volume":"101","author":"D Trabattoni","year":"2003","journal-title":"Blood"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"8978","DOI":"10.1128\/JVI.00314-08","article-title":"Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain.","volume":"82","author":"P Wang","year":"2008","journal-title":"J Virol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1086\/323395","article-title":"Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999).","volume":"184","author":"JS Yang","year":"2001","journal-title":"J Infect Dis"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.4049\/jimmunol.178.5.2699","article-title":"Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection.","volume":"178","author":"JH Chu","year":"2007","journal-title":"J Immunol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0065-3527(03)60004-7","article-title":"Immune modulation by flaviviruses.","volume":"60","author":"NJ King","year":"2003","journal-title":"Adv Virus Res"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1128\/IAI.62.6.2345-2353.1994","article-title":"Treatment with anti-interleukin-10 monoclonal antibody enhances early resistance to but impairs complete clearance of Listeria monocytogenes infection in mice.","volume":"62","author":"RD Wagner","year":"1994","journal-title":"Infect Immun"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.4049\/jimmunol.158.5.2259","article-title":"Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice.","volume":"158","author":"WJ Dai","year":"1997","journal-title":"J Immunol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1084\/jem.178.3.1041","article-title":"Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor\/IL-12 synthesis in accessory cells.","volume":"178","author":"A D'Andrea","year":"1993","journal-title":"J Exp Med"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.4049\/jimmunol.147.11.3815","article-title":"IL-10 inhibits cytokine production by activated macrophages.","volume":"147","author":"DF Fiorentino","year":"1991","journal-title":"J Immunol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.4049\/jimmunol.146.10.3444","article-title":"IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells.","volume":"146","author":"DF Fiorentino","year":"1991","journal-title":"J Immunol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0955-2235(92)90020-I","article-title":"Interleukin 10: an overview.","volume":"4","author":"D Rennick","year":"1992","journal-title":"Prog Growth Factor Res"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"8956","DOI":"10.1128\/JVI.01118-08","article-title":"Tumor necrosis factor alpha protects against lethal West Nile virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system.","volume":"82","author":"B Shrestha","year":"2008","journal-title":"J Virol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.virol.2008.11.047","article-title":"West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: Transmigration across the in vitro blood-brain barrier.","volume":"385","author":"S Verma","year":"2009","journal-title":"Virology"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1099\/vir.0.83345-0","article-title":"Increased blood-brain barrier permeability is not a primary determinant for lethality of West Nile virus infection in rodents.","volume":"89","author":"JD Morrey","year":"2008","journal-title":"J Gen Virol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0006-8993(89)91079-2","article-title":"Sodium dodecylsulphate induces a breach in the blood-brain barrier and enables a West Nile virus variant to penetrate into mouse brain.","volume":"496","author":"D Kobiler","year":"1989","journal-title":"Brain Res"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1126\/science.286.5448.2331","article-title":"Isolation of West Nile virus from mosquitoes, crows, and a Cooper's hawk in Connecticut.","volume":"286","author":"JF Anderson","year":"1999","journal-title":"Science"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1086\/428507","article-title":"Use of RNA interference to prevent lethal murine west nile virus infection.","volume":"191","author":"F Bai","year":"2005","journal-title":"J Infect Dis"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1128\/JVI.01840-06","article-title":"Antiviral peptides targeting the west nile virus envelope protein.","volume":"81","author":"F Bai","year":"2007","journal-title":"J Virol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1128\/JVI.00489-06","article-title":"PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons.","volume":"80","author":"MA Samuel","year":"2006","journal-title":"J Virol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1371\/journal.ppat.0030106","article-title":"Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms.","volume":"3","author":"S Daffis","year":"2007","journal-title":"PLoS Pathog"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"6784","DOI":"10.4049\/jimmunol.166.11.6784","article-title":"Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells.","volume":"166","author":"LK Selin","year":"2001","journal-title":"J Immunol"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1000610","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T22:55:21Z","timestamp":1685141721000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1000610"}},"subtitle":[],"editor":[{"given":"Michael","family":"Gale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,10,9]]},"references-count":69,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2009,10,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1000610","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,9]]}}}